| Ytd | -13.16% | |
| 1y | -3.39% |
| Open | 71.30 | Prev Close | 71.72 | Low | 70.29 | High | 71.55 | Mkt Cap | 32.17B |
| Vol | 3.31M | Avg Vol | 4.61M | EPS | 4.34 | P/E | 16.41 | Forward P/E | 13.17 |
| Beta | 0.82 | Short Ratio | 3.23 | Inst. Own | 94.12% | Dividend | 0.14 | Div Yield | 0.20 |
| Ex Div Date | 07-24 | Earning | 10-28 | 50-d Avg | 67.59 | 200-d Avg | 72.81 | 1yr Est | 82.50 |
Investors with an interest in Medical - Products stocks have likely encountered both GE HealthCare T
GEHC expands its Vivid cardiovascular ultrasound portfolio with three systems featuring AI tools and
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) recently achieved CE Mark for Photonova Spect
GE HealthCare (GEHC) reported earnings 30 days ago. What's next for the stock?
GE HealthCare (Nasdaq: GEHC) today announced three additions to its Vivid⢠cardiovascular ultrasou
Vivid™ Explorer, Vivid™ Advanced and Vivid™ Focus systems bring cSound™ imaging with capabilities de
CHICAGO--(BUSINESS WIRE)--GE HealthCare today announced three additions to its Vivid™ cardiovascular
GE HealthCare (Nasdaq: GEHC) is announcing that members of its management team will present at the f
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) is announcing that members of its management
Bank of Nova Scotia increased its position in GE HealthCare Technologies Inc. (NASDAQ: GEHC) by 40.7
GEHC's 11.1% order growth and record $23.9B backlog improve revenue visibility, but PCS execution an
GEHC's valuation discount and growth in imaging and diagnostics support the case, but PCS weakness,
GE HealthCare's record backlog, strong Pharmaceutical Diagnostics growth and AI innovation support i
Barrow Hanley Mewhinney and Strauss LLC grew its holdings in GE HealthCare Technologies Inc. (NASDAQ
Allworth Financial LP trimmed its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ: GEH
LOS ANGELES, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP, a leading national
Tap four stocks with increasing P/E ratios to try out an out-of-the-box approach.
BENSALEM, Pa., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith continues its invest
LOS ANGELES, Aug. 19, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz continues its invest
BTIG analyst Ryan Zimmerman reiterates GE HealthCare Techs (NASDAQ:GEHC) with a Buy and maintains
GE HealthCare said on Tuesday it had appointed William Grogan chief financial officer, effective Se
GE HealthCare (Nasdaq: GEHC), a leading global precision care innovator, today announced the appoint
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC), a leading global precision care innovator, t
Nelson Peltz sharply increased his GE HealthCare stake while maintaining his sizable GE Aerospace po
Investors interested in Medical - Products stocks are likely familiar with GE HealthCare Technologie
GE HealthCare (GEHC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about t
Following the introduction of Invenia™ ABUS Prime at the Society of Breast Imaging Annual Symposium,
UBS analyst Graham Doyle maintains GE HealthCare Techs (NASDAQ:GEHC) with a Neutral and raises th
Citigroup analyst Joanne Wuensch maintains GE HealthCare Techs (NASDAQ:GEHC) with a Neutral and r
Evercore ISI Group analyst Vijay Kumar maintains GE HealthCare Techs (NASDAQ:GEHC) with a Outperf
Wells Fargo analyst Larry Biegelsen maintains GE HealthCare Techs (NASDAQ:GEHC) with a Overweight
BTIG analyst Ryan Zimmerman maintains GE HealthCare Techs (NASDAQ:GEHC) with a Buy and raises the
GE HealthCare (GEHC) stock surged after Q2 earnings beat estimates, driven by strong imaging and dia
U.S. stocks fell with the Dow Jones down 600 points. Ford's Q2 EPS and FY26 guidance boosted sha
Gainers Autonomix Medical (NASDAQ:AMIX) shares moved upwards by 62.5% to $4.47 during Wednesday'
GE HealthCare Techs (NASDAQ:GEHC) affirms FY2026 Adj EPS guidance from $4.80-$5.00 to $4.80-$5.00 vs
GE HealthCare Techs (NASDAQ:GEHC) reported quarterly earnings of $1.13 per share which beat the anal
GE HealthCare (Nasdaq: GEHC) today announced that Jay Saccaro will step down as Vice President and C
UBS analyst Graham Doyle maintains GE HealthCare Techs (NASDAQ:GEHC) with a Neutral and lowers th
More than 1,300 pieces of technology to be added across Catholic Health hospitals and ambulatory loc
BMO Capital initiates coverage on GE HealthCare Techs (NASDAQ:GEHC) with a Market Perform rating a
A novel theranostics study explores imaging- and data-informed approaches to support individualized
RBC Capital analyst Shagun Singh initiates coverage on GE HealthCare Techs (NASDAQ:GEHC) with a O
https://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/anesthesia-delivery-syst
Marking the evolution of MIM AI-enabled auto-contouring software, MIM Contour ProtégéAI+ 2.0 introdu
Nuclear medicine is reaching an inflection point as advances in imaging, theranostics and radiopharm
UBS analyst Graham Doyle upgrades GE HealthCare Techs (NASDAQ:GEHC) from Sell to Neutral and lowe
As the global magnetic resonance (MR) community convenes for the International Society for Magnetic
JP Morgan analyst Robbie Marcus maintains GE HealthCare Techs (NASDAQ:GEHC) with a Neutral and lo